{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:49:36Z","timestamp":1780375776037,"version":"3.54.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.schres.2018.06.038","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T05:07:17Z","timestamp":1529557637000},"page":"398-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Combination therapy of electroconvulsive therapy and aripiprazole for dopamine supersensitivity psychosis"],"prefix":"10.1016","volume":"202","author":[{"given":"Nobuhisa","family":"Kanahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makihiko","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.06.038_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neubiorev.2017.09.027","article-title":"Dopamine, the antipsychotic molecule: a perspective on mechanisms underlying antipsychotic response variability","volume":"85","author":"Amato","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2018.06.038_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-9964(91)90050-2","article-title":"Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment","volume":"5","author":"Chouinard","year":"1991","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.06.038_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000477313","article-title":"Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy","volume":"86","author":"Chouinard","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.schres.2018.06.038_bb0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/JCP.0b013e31828ea95c","article-title":"Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis","volume":"33","author":"Iyo","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.06.038_bb0025","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 12","key":"10.1016\/j.schres.2018.06.038_bb0030","first-page":"4","article-title":"The evolving definition of treatment resistance","volume":"60","author":"Peuskens","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.038_bb0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4088\/JCP.08m04746blu","article-title":"Electroconvulsive therapy decreases dopamine D2 receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [11C]FLB 457","volume":"71","author":"Saijo","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.038_bb0040","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/schbul\/sbr006","article-title":"Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis","volume":"38","author":"Tadokoro","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.06.038_bb0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0269881115570083","article-title":"Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia","volume":"29","author":"Takase","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.06.038_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2016.01.013","article-title":"Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: an analysis of multi-factors predicting long-term prognosis","volume":"170","author":"Yamanaka","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.06.038_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2011.564653","article-title":"Using ECT in schizophrenia: a review from a clinical perspective","volume":"13","author":"Zervas","year":"2011","journal-title":"World J. Biol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418303736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418303736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T07:48:46Z","timestamp":1543996126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418303736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":11,"alternative-id":["S0920996418303736"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.06.038","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy of electroconvulsive therapy and aripiprazole for dopamine supersensitivity psychosis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}